PROCEPT BioRobotics Return on Investment 2021-2024 | PRCT
Current and historical return on investment (ROI) values for PROCEPT BioRobotics (PRCT) over the last 10 years.
| PROCEPT BioRobotics ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-12-31 | $-0.10B | $0.45B | -28.42% |
| 2024-09-30 | $-0.11B | $0.29B | -34.43% |
| 2024-06-30 | $-0.11B | $0.30B | -34.08% |
| 2024-03-31 | $-0.11B | $0.32B | -36.39% |
| 2023-12-31 | $-0.11B | $0.33B | -39.29% |
| 2023-09-30 | $-0.11B | $0.35B | -40.46% |
| 2023-06-30 | $-0.10B | $0.21B | -42.17% |
| 2023-03-31 | $-0.09B | $0.23B | -35.77% |
| 2022-12-31 | $-0.08B | $0.25B | -28.95% |
| 2022-09-30 | $-0.07B | $0.27B | -24.58% |
| 2022-06-30 | $-0.06B | $0.29B | -20.48% |
| 2022-03-31 | $-0.06B | $0.31B | -24.61% |
| 2021-12-31 | $-0.05B | $0.32B | -33.03% |
| 2021-06-30 | $-0.04B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $2.924B | $0.225B |
| PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif. | |||